For the first time, this Ar Event was available solely online, but that didn’t stop viewers from interacting on all of the available platforms - Zoom, Facebook Live and YouTube - with more than 200 questions shared with our panel of experts.  According to Dr. Bill Richards (who you’ll get to know later!), we are “Moving into new terrain… and we welcome you to join us!”

For millennia, humans have “tripped” on psychedelic substances for spiritual growth, healing or recreational purposes. Today, the healthcare community has renewed interest in the potential of psychedelics for mental health.

In this Ar event, Tiago Quendera and Tatiana Silva, two neuroscience PhD students at the Champalimaud Centre for the Unknown, will take you through the ups and downs of the history of psychedelics and their use in research.

CRS21 will focus on the interface of neuroscience, artificial intelligence and machine learning with the main goal of starting an interdisciplinary conversation about the deep conceptual problems that emerge when trying to understand how intelligent behaviour is generated in animals and machines.
 

The panel included three in-house specialists: immunologist Thiago Carvalho and oncologists Fátima Cardoso, head of the Breast Unit at the Champalimaud Clinical Centre, and Cristina João, a haematologist in the Haemato-Oncology Unit who also heads the Myeloma and Lymphoma Research Lab at Champalimaud Research.

Um ano após o início da Pandemia de COVID-19, a doença continua a ter um forte impacto na vida das pessoas, nomeadamente naqueles que manifestam maior risco e suscetibilidade a doenças graves, por apresentarem comorbidades, como é o caso dos doentes oncológicos.